Equal effects of clopidogrel as compared to aspirin on circulating markers of inflammation in patients with coronary heart disease

被引：0
|
作者：
Solheim, S. [1 ]
Pettersen, A. [1 ]
Arnesen, H. [1 ]
Seljeflot, I. [1 ]
机构：
[1] Univ Oslo, Ullevaal Hosp, Clin Cardiovasc Res Unit, N-0407 Oslo, Norway
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2006年 / 7卷 / 03期
关键词：
D O I：
10.1016/S1567-5688(06)81154-2
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：284 / 284
页数：1
相关论文
共 50 条
  • [41] GENETIC ASSOCIATION OF INADEQUATE ANTIPLATELET EFFECTS OF ASPIRIN AND CLOPIDOGREL IN PATIENTS WITH CORONARY ARTERY DISEASE (CAD): A PRELIMINARY STUDY
    Arya, V.
    Bhargava, M.
    Saraf, A.
    Mohanty, A.
    Sawhney, J.
    HAEMATOLOGICA, 2012, 97 : 684 - 684
  • [42] Prevention of coronary heart disease with aspirin and clopidogrel: efficacy, safety, costs and cost-effectiveness
    Ho, WK
    Hankey, GJ
    Eikelboom, JW
    EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (03) : 493 - 503
  • [43] Aspirin and Clopidogrel response in patients with acute coronary syndrome
    Braga, F.
    Lavall, G.
    Sterque, A.
    Albuquerque, F.
    Gouvea, G.
    Neno, A. C.
    Kezen, J.
    Max, R.
    Sophia, E.
    Hellmuth, B.
    CIRCULATION, 2008, 118 (12) : E291 - E291
  • [44] PROGNOSTIC SIGNIFICANCE OF NON-SPECIFIC SYSTEMIC INFLAMMATION MARKERS IN PATIENTS WITH CORONARY HEART DISEASE
    Romanova, V. O.
    Kuzminova, N. V.
    Ivankova, A. V.
    Lozinsky, S. E.
    Kniazkova, I. I.
    Poberezhets, O. L.
    Repetenko, M. V.
    WORLD OF MEDICINE AND BIOLOGY, 2024, 88 (02): : 129 - 133
  • [45] Low-Dose Rivaroxaban vs. Aspirin in Addition to Clopidogrel After Percutaneous Coronary Intervention in Coronary Atherosclerotic Heart Disease Patients with Gastrointestinal Disease
    Li, Yue
    Zhou, Tienan
    Liu, Yan
    Qi, Junxian
    Zhang, Lei
    Gu, Ruoxi
    Sun, Dongyuan
    Wang, Xiaozeng
    CARDIOVASCULAR DRUGS AND THERAPY, 2025,
  • [46] Hypertension as a Risk Factor for Aspirin and Clopidogrel Resistance in Patients With Stable Coronary Artery Disease
    Akturk, Ibrahim Faruk
    Caglar, Fatma Nihan
    Erturk, Mehmet
    Tuncer, Nilgun
    Yalcin, Ahmet Arif
    Surgit, Ozgur
    Uzun, Fatih
    Caglar, Ilker Murat
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2014, 20 (07) : 749 - 754
  • [47] Treatment with aspirin and clopidogrel inhibit thrombin generation in patients with stable coronary artery disease
    Bandi, A.
    Mosialos, L.
    Katsiki, N.
    Zarifis, J.
    Vassara, C.
    Kaprinis, I
    Kiskinis, D.
    Elalamy, I
    Gerotziafas, G. T.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 586 - 586
  • [48] Clinical determinants of aspirin and clopidogrel resistance in patients with coronary artery disease undergoing PCI
    Marcucci, R.
    Buonamici, P.
    Santini, A.
    Paniccia, R.
    Prisco, D.
    Antoniucci, D.
    Abbate, R.
    Gensini, G. F.
    EUROPEAN HEART JOURNAL, 2006, 27 : 749 - 749
  • [49] Soybean oil lowers circulating cholesterol levels and coronary heart disease risk, and has no effect on markers of inflammation and oxidation
    Messina, Mark
    Shearer, Gregory
    Petersen, Kristina
    NUTRITION, 2021, 89
  • [50] Aspirin resistance and endothelial dysfunction in patients with coronary heart disease
    Pamukcu, B.
    Onur, I.
    Oflaz, H.
    Goren, M. T.
    Bugra, Z.
    Umman, S.
    Meric, M.
    Nisanci, Y.
    EUROPEAN HEART JOURNAL, 2007, 28 : 713 - 713
12345